Abbott Laboratories (ABT) Operating Income Growth (1y) (2010 - 2026)
Abbott Laboratories (ABT) Operating Income Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 20.97% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -18.12% |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 90.95% |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 74.18% |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | 46.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.56% |
| Dec 31, 2025 | 17.79% |
| Sep 30, 2025 | 10.65% |
| Jun 30, 2025 | 22.95% |
| Mar 31, 2025 | 22.15% |
| Dec 31, 2024 | 7.36% |
| Sep 30, 2024 | 12.87% |
| Jun 30, 2024 | 8.24% |
| Mar 31, 2024 | -8.15% |
| Dec 31, 2023 | 36.50% |
| Sep 30, 2023 | -6.95% |
| Jun 30, 2023 | -35.10% |
| Mar 31, 2023 | -48.18% |
| Dec 31, 2022 | -45.16% |
| Sep 30, 2022 | -30.48% |
| Jun 30, 2022 | 70.69% |
| Mar 31, 2022 | 38.07% |
| Dec 31, 2021 | -2.22% |
| Sep 30, 2021 | 70.30% |
| Jun 30, 2021 | 107.14% |